Skip to content

Relationship between serum FXIII levels and prognosis in ICH patients

Relationship between serum FXIII levels and prognosis in ICH patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112595
Enrollment
Unknown
Registered
2025-11-17
Start date
2022-10-02
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Hemorrhage

Interventions

Low-FXIII level gourp:None
Normal-FXIII level gourp:None

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Male or female patients aged between 16 and 75 years old; 2. The time from onset of cerebral hemorrhage to blood draw is less than 12 hours; 3. No blood products or clotting factors were administered before the blood draw, and no neurosurgical intervention was given. 4. The patient's head CT confirmed spontaneous cerebral hemorrhage. 5. The patient or guardian signs the informed consent form for enrollment.

Exclusion criteria

Exclusion criteria: 1. Patient's CT scan indicates an epidural hematoma/subdural hematoma volume>20m; 2. Patient has a history of head trauma; 3. Merge other major underlying diseases. 4. The patient or guardian refuses to participate in the clinical trial.

Design outcomes

Primary

MeasureTime frame
FXIII plasma level;

Countries

China

Contacts

Public ContactLv Ke

The First Affiliated Hospital of Chongqing Medical University

luke@hospital.cqmu.edu.cn+86 134 5299 1692

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026